Procter & Gamble
PG
$147.68
-1.80%
Procter & Gamble is a global consumer goods behemoth operating in the Household & Personal Products industry, with a vast portfolio of essential brands like Tide, Pampers, and Gillette. The company is a dominant market leader, distinguished by its unparalleled brand equity, massive scale, and extensive global distribution network. The current investor narrative centers on its resilience as a defensive staple amid economic uncertainty, its ability to navigate persistent cost inflation through pricing power, and its ongoing focus on productivity and portfolio optimization to drive margin expansion, as evidenced by recent quarterly results and analyst discussions around its steady performance.…
PG
Procter & Gamble
$147.68
Related headlines
Investment Opinion: Should I buy PG Today?
Rating & Thesis: Hold. PG is a high-quality defensive staple currently trading at a premium valuation that prices in its stability but offers limited near-term capital appreciation potential, given its low growth trajectory and recent market underperformance. The analyst consensus leans bullish, but the lack of a clear average target price and the stock's technical weakness support a neutral stance.
Supporting Evidence: The Hold rating is supported by four key data points: 1) A premium forward PE of 21.2x versus likely sector averages in the high teens, 2) Stagnant revenue growth of 1.5% YoY, 3) Exceptional but potentially peak profitability with a net margin of 19.5% and ROE of 30.7%, and 4) A technical position near the lower end of its 52-week range, suggesting most negative news is priced in but lacking a catalyst for a breakout.
Risks & Conditions: The two biggest risks to this thesis are a growth slowdown below 1% or a sector-wide de-rating that compresses its premium PE. This Hold would upgrade to a Buy if the forward PE compresses below 20x while growth and margins remain stable, or if a market downturn increases the premium on its defensive attributes. It would downgrade to a Sell if revenue growth turns negative or if operating margins contract by more than 200 basis points. Relative to its own history and the sector, PG is fairly valued to slightly overvalued, with the market paying for quality and stability rather than growth.
Sign up to view all
PG 12-Month Price Forecast
PG is a quintessential 'hold' in a diversified portfolio: a fortress of profitability and stability, but not a compelling engine for capital appreciation in the current market environment. The neutral stance reflects the offsetting forces of its high-quality fundamentals against its rich valuation and low growth. Confidence is medium because the near-term path depends heavily on market sentiment—whether investors will pay up for safety or continue to chase growth. The stance would upgrade to bullish if the forward PE falls below 20x on stable earnings, creating a margin of safety. It would turn bearish if revenue growth turns negative, signaling a breakdown in its core business model.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $191.98 and implied upside of +30.0% versus the current price.
Average Target
$191.98
12 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
12
covering this stock
Price Range
$118 - $192
Analyst target range
The stock is covered by 12 analysts, indicating substantial institutional interest. The consensus sentiment leans bullish, as evidenced by recent institutional ratings which include actions like 'Overweight' from Wells Fargo and JP Morgan and a 'Buy' from UBS, though there is a mix of 'Hold' ratings as well. The average target price is not explicitly provided in the analyst data, but the estimated EPS and revenue averages give a basis for valuation models; without a specific consensus price target, the implied upside cannot be calculated, but the distribution of actions suggests a generally favorable view. The target range for estimated EPS is $7.88 to $8.20, and for revenue it's $97.89 billion to $100.93 billion, indicating a relatively tight spread and thus higher conviction in the company's near-term financial trajectory. The high end of the EPS range assumes successful execution on growth and margin initiatives, while the low end likely factors in potential macroeconomic headwinds or competitive pressures; the recent pattern of ratings shows some stability with a few upgrades, reinforcing the stock's status as a core holding.
Bulls vs Bears: PG Investment Factors
The investment debate for PG centers on the tension between its premium valuation and its low-growth, defensive profile. The bull case is anchored in its exceptional quality—world-class profitability, strong cash generation, and low volatility—which justifies a premium in uncertain times. The bear case focuses on valuation compression risk, as the stock's high PE and PEG multiples are difficult to sustain with ~1.5% revenue growth, especially when it is underperforming a strong bull market. Currently, the bear side has stronger near-term evidence due to the stark -30% relative underperformance versus the S&P 500, suggesting the market is penalizing its lack of growth. The single most important factor is whether PG's defensive characteristics will be rewarded (in a market downturn) or if its premium valuation will continue to compress in a growth-oriented market.
Bullish
- Exceptional Profitability & Cash Flow: PG's net margin of 19.5% and ROE of 30.7% are hallmarks of a dominant, well-run business. The company generates massive free cash flow ($14.85B TTM), funding its generous dividend (2.5% yield) and buybacks internally.
- Defensive Staple with Low Volatility: A beta of 0.385 means PG is 61.5% less volatile than the market, providing a defensive anchor for portfolios. This characteristic is prized during economic uncertainty, as evidenced by its stable 1.5% YoY revenue growth despite market turmoil.
- Strong Pricing Power & Margin Resilience: Gross margin of 51.2% and operating margin of 24.3% demonstrate significant pricing power. The company has successfully navigated cost inflation, with margins showing resilience and supporting a high-quality earnings stream.
- Analyst Conviction & Stable Outlook: Coverage by 12 analysts shows strong institutional interest, with recent actions including 'Overweight' and 'Buy' ratings. The tight EPS forecast range ($7.88-$8.20) indicates high conviction in the company's predictable near-term financial trajectory.
Bearish
- Premium Valuation with Low Growth: A trailing PE of 24.5x and forward PE of 21.2x trade at a premium to the Consumer Defensive sector. The PEG ratio of 3.09 is expensive, indicating the market is paying a high price for its modest 1.5% revenue growth.
- Persistent Underperformance vs. Market: PG has significantly underperformed the S&P 500, with a 1-year price change of -4.8% versus the index's +25% gain. This -29.8% relative strength deficit highlights a lack of investor appetite for low-growth staples in a rallying market.
- Mature Market with Stagnant Top Line: Revenue growth is essentially flat, with the latest quarter at $22.21B showing only 1.5% YoY growth. The prior quarter's revenue of $22.39B confirms the company operates in a low-growth, mature market environment.
- Vulnerability to Sector Rotation: Recent news highlights a 'rotation trade' from growth to value, but PG's premium valuation makes it susceptible to outflows if the market favors high-growth sectors like tech, as seen with Intel's 23% rally on AI demand.
PG Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of -4.83%, significantly underperforming the S&P 500's 24.99% gain. As of the latest close of $150.38, the price is trading at approximately 86% of its 52-week range ($137.62 to $167.25), indicating it is closer to the lower bound, which may suggest a value opportunity but also reflects persistent selling pressure and negative relative strength. Recent momentum shows a short-term recovery attempt, with a 1-month gain of 6.43% and a 3-month gain of 4.23%, which diverges positively from the longer-term downtrend and could signal a potential mean reversion or stabilization phase after the earlier decline. Key technical support is clearly defined at the 52-week low of $137.62, while resistance sits at the 52-week high of $167.25; a sustained break above resistance would signal a major trend reversal, while a breakdown below support could trigger a new leg down. The stock's beta of 0.385 indicates it is 61.5% less volatile than the broader market, which is characteristic of a defensive staple and informs a lower-risk profile for position sizing.
Beta
0.39
0.39x market volatility
Max Drawdown
-18.8%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-7.2%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +2.2% | -0.2% |
| 3m | +3.2% | +14.0% |
| 6m | +2.2% | +7.8% |
| 1y | -7.2% | +25.3% |
| ytd | +4.2% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth is stable but modest, with the most recent quarterly revenue of $22.21 billion representing a year-over-year increase of 1.49%. The multi-quarter trend shows revenue has been relatively flat, with the prior quarter (Q1 2026) at $22.39 billion, indicating the company is navigating a low-growth, mature market environment where pricing is likely offsetting volume pressures. The company is highly profitable, reporting net income of $4.33 billion for the quarter, translating to a robust net margin of 19.5%. Gross margin for the quarter was 51.22%, and the trailing twelve-month operating margin is 24.26%, reflecting strong pricing power and cost management that are hallmarks of the industry; margins have shown resilience but some compression from higher commodity costs is evident when comparing to the 51.37% gross margin in the prior quarter. The balance sheet is solid, with a debt-to-equity ratio of 0.68, indicating a moderate but manageable level of leverage. Financial health is further underscored by strong cash generation, with free cash flow over the trailing twelve months of $14.85 billion and a return on equity of 30.7%, demonstrating the company's ability to fund its generous dividend and share buybacks internally while delivering high returns to shareholders.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 24.48x, while the forward PE is 21.19x; the lower forward multiple suggests the market anticipates modest earnings growth, with analysts projecting FY2026 EPS of approximately $8.00. Compared to the Consumer Defensive sector, Procter & Gamble's trailing PE of 24.48x trades at a premium; while specific industry average data is not provided in the valuation dataset, the stock's premium is typically justified by its superior brand moat, consistent profitability, and defensive characteristics, though the PEG ratio of 3.09 indicates growth expectations are priced expensively. Historically, the current trailing PE of 24.48x sits above the multi-year range observed in the historical ratios data, which has fluctuated between approximately 19x and 32x over recent quarters; trading near the higher end of its own historical band suggests the market is pricing in stable, high-quality earnings but leaves limited room for multiple expansion, posing a risk if growth disappoints.
PE
23.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PG's primary financial risk is not leverage (D/E of 0.68 is manageable) but its dependence on pricing to drive earnings in a low-volume growth environment. With revenue growth of just 1.5%, any failure to maintain its 51.2% gross margin through pricing actions would directly pressure the bottom line. Furthermore, the company's high payout ratio of 62% commits a significant portion of its robust cash flow to the dividend, which could limit financial flexibility if a major acquisition or reinvestment opportunity arises during a downturn.
Market & Competitive Risks: The most pressing market risk is valuation compression. Trading at a trailing PE of 24.5x, which is above its own historical range and at a sector premium, PG is vulnerable to multiple contraction if growth disappoints or if investor sentiment rotates away from defensive staples. Its low beta of 0.385, while a defensive strength, also means it is likely to lag in strong bull markets, as evidenced by its -30% relative strength over the past year. Competitive risks include private label encroachment and potential regulatory pressures on consumer goods giants, though PG's brand equity provides a substantial moat.
Worst-Case Scenario: A severe recession coupled with a sustained spike in commodity costs (e.g., a prolonged European energy crisis) could simultaneously compress PG's margins and trigger multiple contraction as investors flee all equities. In this scenario, volume declines could outpace pricing power, leading to an earnings miss. The stock could realistically re-test its 52-week low of $137.62, representing a downside of approximately -8.5% from the current price of $150.38. A more severe bear case, factoring in a full derating to the lower end of its historical PE range, could see a drawdown approaching the stock's recent max drawdown of -18.75%.
FAQ
The key risks are: 1) Valuation Compression: The primary risk is its premium multiple contracting if growth disappoints or market sentiment shifts. 2) Stagnant Growth: Revenue growth of just 1.5% leaves little room for error and makes the stock vulnerable to volume declines. 3) Macroeconomic: Over half of sales are international, exposing it to regional issues like the European energy crisis, which could pressure its 51.2% gross margin. 4) Market Sentiment: Its low beta of 0.385 means it often lags in strong bull markets, as seen in its -30% relative strength over the past year.
Our 12-month outlook presents three scenarios. The Base Case (60% probability) sees the stock trading between $150 and $165, driven by stable execution and its dividend, with EPS near $8.00. The Bull Case (25% probability) targets $167 to $175, requiring a market downturn that boosts demand for defensive stocks and margin preservation. The Bear Case (15% probability) risks a drop to $137-$145 on multiple compression and an earnings miss. The Base Case is most likely, assuming the status quo of low growth and a stable premium multiple persists.
PG is fairly valued to slightly overvalued relative to its growth prospects. Its forward PE of 21.2x and trailing PE of 24.5x trade at a premium to the Consumer Defensive sector average. The high PEG ratio of 3.09 confirms that growth is priced expensively. Compared to its own historical PE range (approximately 19x to 32x), it sits above the midpoint. This valuation implies the market is paying a premium for PG's exceptional profitability, stability, and defensive characteristics, not for growth.
PG is a good buy for a specific type of investor: those seeking a low-volatility, defensive anchor for their portfolio with a reliable 2.5% dividend yield. However, for investors seeking capital appreciation, it is less compelling due to its premium valuation (21.2x forward PE) and low revenue growth (~1.5%). The stock's significant underperformance versus the S&P 500 (-4.8% vs. +25% over 1 year) highlights this trade-off. It becomes a more attractive buy if its valuation compresses further, providing a larger margin of safety.
PG is unequivocally a long-term investment. Its value proposition is built on compounding dividends, brand durability, and portfolio stability over decades, not quarterly trading catalysts. The stock's low beta (0.385) makes it unsuitable for short-term traders seeking volatility. Given its current premium valuation, new investors should be prepared to hold for a minimum of 3-5 years to ride out market cycles, collect dividends, and allow the company's fundamental strengths to outweigh near-term multiple fluctuations.